Harmony Biosciences
HRMY
HRMY
204 hedge funds and large institutions have $1.62B invested in Harmony Biosciences in 2023 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 86 increasing their positions, 56 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $1.83B → $1.62B (-$205M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
16% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 38
Holders
204
Holding in Top 10
6
Calls
$9.47M
Puts
$4.32M
Top Buyers
| 1 | +$12.5M | |
| 2 | +$7.21M | |
| 3 | +$3.44M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.89M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.84M |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$14.3M | |
| 3 | -$12.5M | |
| 4 |
Man Group
London,
United Kingdom
|
-$11.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$8.76M |